3 reasons Bernstein strategists are bullish on the EU pharma sector into 2025
 
		
	Investing.com — Bernstein analysts are optimistic about the European pharmaceutical sector as it heads into 2025, despite concerns over policy changes and market headwinds.  The firm outlined its three key reasons…
		 
					 
					 
					 
					 
					 
					 
					 
					